Ivana Magovcevic-Liebisch - Feb 8, 2024 Form 3 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
Director
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Stock symbol
ACRV
Transactions as of
Feb 8, 2024
Transactions value $
$0
Form type
3
Date filed
2/9/2024, 04:34 PM
Previous filing
Nov 20, 2023
Next filing
Mar 1, 2024

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney